Ravi Srinivasan
Keine laufenden Positionen mehr
Profil
Ravi Srinivasan is the founder of StemPar Sciences, Inc. founded in 2012.
Dr. Srinivasan is also the founder of Stratagent Life Sciences, Inc., OncoNano Medicine, Inc. Dr. Srinivasan's former jobs include Director at Corium International, Inc. and Senior Vice President-Research & Development at S.E.A.
Medical Systems, Inc. Dr. Srinivasan's education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from Indian Institute of Technology Bombay.
Ehemalige bekannte Positionen von Ravi Srinivasan
| Unternehmen | Position | Ende |
|---|---|---|
OncoNano Medicine, Inc.
 OncoNano Medicine, Inc. BiotechnologyHealth Technology OncoNano Medicine, Inc. operates as a biotechnology company. It develops pH-activated compounds that digitalize and exploit the variability of pH in disease. The company was founded by Ravi Srinivasan, Jinming Gao, and Baran Sumer in 2014 and is headquartered in Southlake, TX. | Gründer | - |
Stratagent Life Sciences, Inc.
 Stratagent Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Stratagent Life Sciences, Inc. develops non-invasive drug therapies. Its products are based on its proprietary micro jet technology which delivers therapeutic molecules. The company was founded by Ruben Rathnasingham and is headquartered in Los Gatos, CA. | Gründer | - |
StemPar Sciences, Inc.
 StemPar Sciences, Inc. Medical/Nursing ServicesHealth Services StemPar Sciences, Inc. develops cancer drugs treatments. It provides cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy/radiation induced DNA damage. The company was founded by Hoyoung Huh and Mircea Florin Mihaescu in 2012 and is headquartered in Mill Valley, CA. | Gründer | - |
S.E.A. Medical Systems, Inc.
 S.E.A. Medical Systems, Inc. Medical SpecialtiesHealth Technology S.E.A. Medical Systems, Inc. develops medical devices that catch serious or life-threatening intravenous drug errors. It specializes in developing medical devices that catch serious or life-threatening intravenous drug errors before they harm patients. It has created a disruptive platform technology with life-saving product applications, allowing for the identification and characterization of medical solutions in real time. The firm offers IV Check that validates IV preparations and measures pharmacy returns to detect narcotic or scheduled drug diversion. The company was founded in October 2008 by James W. Bennett, Leo Matsiev and Michael J. Weickert and is headquartered in Emerald Hills, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
| CORIUM INTERNATIONAL INC | Direktor/Vorstandsmitglied | - |
Ausbildung von Ravi Srinivasan
| Massachusetts Institute of Technology | Doctorate Degree |
| Indian Institute of Technology Bombay | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
StemPar Sciences, Inc.
StemPar Sciences, Inc. Medical/Nursing ServicesHealth Services StemPar Sciences, Inc. develops cancer drugs treatments. It provides cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy/radiation induced DNA damage. The company was founded by Hoyoung Huh and Mircea Florin Mihaescu in 2012 and is headquartered in Mill Valley, CA. | Health Services |
S.E.A. Medical Systems, Inc.
S.E.A. Medical Systems, Inc. Medical SpecialtiesHealth Technology S.E.A. Medical Systems, Inc. develops medical devices that catch serious or life-threatening intravenous drug errors. It specializes in developing medical devices that catch serious or life-threatening intravenous drug errors before they harm patients. It has created a disruptive platform technology with life-saving product applications, allowing for the identification and characterization of medical solutions in real time. The firm offers IV Check that validates IV preparations and measures pharmacy returns to detect narcotic or scheduled drug diversion. The company was founded in October 2008 by James W. Bennett, Leo Matsiev and Michael J. Weickert and is headquartered in Emerald Hills, CA. | Health Technology |
Stratagent Life Sciences, Inc.
Stratagent Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Stratagent Life Sciences, Inc. develops non-invasive drug therapies. Its products are based on its proprietary micro jet technology which delivers therapeutic molecules. The company was founded by Ruben Rathnasingham and is headquartered in Los Gatos, CA. | Health Technology |
OncoNano Medicine, Inc.
OncoNano Medicine, Inc. BiotechnologyHealth Technology OncoNano Medicine, Inc. operates as a biotechnology company. It develops pH-activated compounds that digitalize and exploit the variability of pH in disease. The company was founded by Ravi Srinivasan, Jinming Gao, and Baran Sumer in 2014 and is headquartered in Southlake, TX. | Health Technology |
